Variables | Anxiety | non-Anxiety | P-value | Deperssion | non-Depression | P-value |
---|---|---|---|---|---|---|
Age,years,mean ± SD | 54.9 ± 8.88 | 55.25 ± 9.62 | 0.86 | 55.26 ± 9.40 | 55.19 ± 9.52 | 0.97 |
Gender (male) | 16 (47.1%) | 67 (40.4%) | 0.47 | 9 (29.0%) | 74 (43.8%) | 0.13 |
Hypertension | 23 (67.6%) | 85 (51.2%) | 0.08 | 19 (61.3%) | 89 (52.7%) | 0.44 |
Diabetes | 3 (8.8%) | 14 (8.4%) | 0.99 | 3 (9.7%) | 14 (8.3%) | 0.99 |
Heart disease | 4 (11.8%) | 21 (12.7%) | 0.99 | 3 (9.7%) | 22 (13..0%) | 0.83 |
1ICVD history | 9 (26.5%) | 28 (16.9%) | 0.19 | 7 (22.6%) | 30 (17.8%) | 0.52 |
Smoking | 5 (14.7%) | 18 (10.8%) | 0.73 | 3 (9.7%) | 20 (11.8%) | 0.97 |
Physical exercise | 23 (67.6%) | 117 (70.5%) | 0.74 | 19 (61.3%) | 121 (71.6%) | 0.25 |
Sleep time | 6.53 ± 1.21 | 6.95 ± 1.18 | 0.06 | 6.29 ± 1.22 | 6.99 ± 1.16 | 0.003 |
Education level, years ≤12 years | 26 (76.5%) | 105 (63.3%) | 0.14 | 22 (71.0%) | 109 (64.5%) | 0.49 |
2Ratio > 100% | 17 (50.0%) | 50 (30.1%) | 0.03 | 14 (45.2%) | 53 (31.4%) | 0.14 |
Diagnosis to treatment time ≤ 3 months | 27 (79.4%) | 131 (78.9%) | 0.99 | 25 (80.6%) | 133 (78.7%) | 0.82 |
mRS progression at discharge | 3 (8.8%) | 7 (4.2%) | 0.49 | 3 (9.7%) | 7 (4.1%) | 0.39 |
Intervention materials (Stent or 3FD) | 29 (85.3%) | 131 (78.9%) | 0.40 | 26 (83.9%) | 134 (79.3%) | 0.56 |
Treatment-related complications | 3 (8.8%) | 5 (3.0%) | 0.27 | 1 (3.2%) | 7 (4.1%) | 0.99 |
Duration since treatment | 31.50 ± 7.82 | 30.49 ± 8.77 | 0.54 | 30.06 ± 8.06 | 30.78 ± 8.72 | 0.67 |
Incomplete obliteration | 2 (6.7%) | 5 (3.6%) | 0.81 | 2 (7.7%) | 5 (3.5%) | 0.66 |
Multiple aneurysms | 7 (20.6%) | 32 (19.3%) | 0.99 | 8 (25.8%) | 31 (18.3%) | 0.34 |
Remain untreated aneurysm | 1 (2.9%) | 9 (5.4%) | 0.86 | 1 (3.2%) | 9 (5.3%) | 0.96 |
Location | 0.04 | 0.32 | ||||
Anterior circulation | 23 (67.6%) | 140 (84.3%) | 24 (77.4%) | 139 (82.2%) | ||
Posterior circulation | 9 (26.5%) | 23 (13.9%) | 5 (16.1%) | 27 (16.0%) | ||
Both | 2 (5.9%) | 3 (1.8%) | 2 (6.5%) | 3 (1.8%) |